Background And Objective: Hepatocellular carcinoma is a common disease with high mortality. Through deep learning methods to analyze HCC CT, the screening classification and prognosis model of HCC can be established, which further promotes the development of computer-aided diagnosis and treatment in the treatment of HCC. However, there are significant challenges in the actual establishment of HCC auxiliary diagnosis model due to data imbalance, especially for rare subtypes of HCC and underrepresented demographic groups. This study proposes a GAN model aimed at overcoming these obstacles and improving the accuracy of HCC auxiliary diagnosis.
Methods: In order to generate liver and tumor images close to the real distribution. Firstly, we construct a new gradient transfer sampling module to improve the lack of texture details and excessive gradient transfer parameters of the deep model; Secondly, we construct an attention module with spatial and cross-channel feature extraction ability to improve the discriminator's ability to distinguish images; Finally, we design a new loss function for liver tumor imaging features to constrain the model to approach the real tumor features in iterations.
Results: In qualitative analysis, the images synthetic by our method closely resemble the real images in liver parenchyma, blood vessels, tumors, and other parts. In quantitative analysis, the optimal results of FID, PSNR, and SSIM are 75.73, 22.77, and 0.74, respectively. Furthermore, our experiments establish classification models for imbalanced data and enhanced data, resulting in an increase in accuracy rate by 21%-34%, an increase in AUC by 0.29 - 0.33, and an increase in specificity to 0.89.
Conclusion: Our solution provides a variety of training data sources with low cost and high efficiency for the establishment of classification or prognostic models for imbalanced data.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cmpb.2024.108252 | DOI Listing |
Discov Oncol
January 2025
Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Liver hepatocellular carcinoma (LIHC) is a highly heterogeneous disease, necessitating the discovery of novel biomarkers to enhance individualized treatment approaches. Recent research has shown the significant involvement of ubiquitin-related genes (UbRGs) in the progression of LIHC. However, the prognostic value of UbRGs in LIHC has not been investigated.
View Article and Find Full Text PDFSupport Care Cancer
January 2025
Department of Medicine, Faculty of Medicine, Srinakharinwirot University, Nakhon Nayok, Thailand.
Background: Malnutrition affects the prognosis and response to treatment in cancer patients. There is no gold standard for nutritional assessment in patients with hepatocellular carcinoma (HCC). This study aimed to compare Patient-Generated Subjective Global Assessment (PG-SGA) and Mini Nutritional Assessment (MNA) in predicting mortality in HCC patients.
View Article and Find Full Text PDFInt J Colorectal Dis
January 2025
Department of Pathomorphology, Medical University of Gdańsk, Gdańsk, Poland.
Purpose: Liver and lung metastases demonstrate distinct biological, particularly immunological, characteristics. We investigated whether preoperative complete blood count (CBC) parameters, which may reflect the immune system condition, predict early dissemination to the liver and lungs in colorectal cancer (CRC).
Methods: In this retrospective single-centre study, we included 268 resected CRC cases with complete 2-year follow-up and analysed preoperative CBC for association with early liver or lung metastasis development.
Eur J Nucl Med Mol Imaging
January 2025
Department of Hepatobiliary Surgery and Liver Transplantation Center, The Fifth Affiliated Hospital of Sun Yat-Sen University, 52 Mei Hua East Road, Zhuhai, 519000, China.
Purpose: Cancer-associated fibroblasts (CAFs) are the primary stromal component of the tumor microenvironment in hepatocellular carcinoma (HCC), affecting tumor progression and post-resection recurrence. Fibroblast activation protein (FAP) is a key biomarker of CAFs. However, there is limited evidence on using FAP as a target in near-infrared (NIR) fluorescence imaging for HCC.
View Article and Find Full Text PDFVirchows Arch
January 2025
Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
Liver masses are common in children, however primary malignant neoplasms are rare, representing only 1% of all pediatric cancers. Hepatocellular neoplasms are the most common primary liver malignancies and hepatoblastoma (HB) is the most frequently diagnosed. The incidence of HB, which is increasing, is approximately of 2 cases per million in the United States, followed by hepatocellular carcinoma (HCC).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!